Skip to main content

Table 1 Patient and Treatment characteristics

From: Long term results of postoperative Intensity-Modulated Radiation Therapy (IMRT) in the treatment of Squamous Cell Carcinoma (SCC) located in the oropharynx or oral cavity

 

n

%

 

n

%

Age

  

Follow-up

  

 median

58 yrs

 median

55 mo

 min

35 yrs

 min

5 mo

 max

85 yrs

 max

150 mo

Gender

  

RT break > 3d

  

 male

63

84

 yes

3

4

 female

12

16

 no

72

96

Localisation

  

SIB

  

 oral cavity

18

24

 yes

63

84

 oropharynx

57

76

 no

12

16

pT stage

  

Number of beams

  

 pT1

23

31

 median

9

 pT2

36

48

 min

5

 pT3

9

12

 max

10

 pT4a

7

9

   
   

TD nodal

  

pN stage

  

 median

54 Gy

 pN0

12

16

 min

50 Gy

 pN1

12

16

 max

60 Gy

 pN2a

5

7

   

 pN2b

39

52

TD Boost

  

 pN2c

7

9

 median

66 Gy

   

 min

60 Gy

clinical stage (UICC6)

  

 max

70.4 Gy

 stage 1

3

4

   

 stage 2

7

9

SD nodes

  

 stage 3

13

17

 median

1.8 Gy

 stage 4a

52

69

 min

1.8 Gy

   

 max

2 Gy

Grading

     

 G1

2

3

SD Boost

  

 G2

43

57

 median

2.2 Gy

 G3

30

40

 min

2 Gy

   

 max

2.33 Gy

ECE

     

 yes

22

29

Chemotherapy

  

 no

53

71

 yes

53

71

   

 no

22

29

Perineural invasion

     

 Pn0

70

93

CHT scheme/compl.

  

 Pn1

5

7

 Cis weekly

47

89a

   

 Carbo/5-FU

5

9a

Number of pos. nodes

  

 Cetuximab

1

1a

 n ≤ 2

44

59

 >80 % of scheduled

41

77a

 n > 2

31

41

 <80 % of scheduled

12

23a

Resection margin

  

Neck dissection

  

 R0

48

64

 ipsilateral

34

45

 R1

27

36

 bilateral

41

55

  1. Yrs years, min minimum, max maximum, n number, %:percentage, UICC6 union international contre le cancer staging manual 6th edition, ECE extracapsular extension, pos. positive, RT radiation therapy, d days, mo months, TD total dose, SD: single dose, CHT chemotherapy, compl.:completion, Cis cisplatin, Carbo carboplatin, 5-FU5-fluorouracil, SIB simultaneously integrated boost, apercentage of 53 patients with CHT